The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Payer CEOs Sharpen Attacks on No Surprises Arbitration

Health insurance executives are turning up the volume against the No Surprises Act's arbitration system, known as independent dispute resolution, or IDR. On Cigna's second-quarter earnings call July 30, President and CEO Brian Evanko said the company backs the law's goal of shielding consumers from surprise medical bills but sees the arbitration mechanism being misused in practice, according to Becker's Hospital Review.

"We're seeing some clear abuses of the IDR vehicle in practice," Evanko said. His comments add to a growing chorus of payer leaders framing IDR as a driver of higher out-of-network payouts rather than a narrow backstop for genuine billing disputes.

The 2020 law created IDR so insurers and providers could settle out-of-network payment fights through a neutral arbiter, keeping patients out of the middle. But case volume has vastly exceeded federal projections, and providers, backed by favorable court rulings, have won a large share of disputes. The escalating rhetoric signals payers will keep pressing regulators and courts to tighten how the process works.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.